GOSSAMER BIO INC
GOSSNASDAQ🏆 #4279 by market capEarnings Nov 3 · PreUS Equity
$11.58▲ $0.06 (+0.52%)
🌅 Pre-market$11.59▲ 0.09%Regular close · extended-hours price shownTrack GOSS
Get earnings, price moves & breaking news on Telegram
24h▲ 0.5%
7d▲ 5.9%
14d▲ 4.9%
30d▼ 14.3%
ytd▼ 95.3%
1y▼ 94.5%
🏦Market Cap
$71M
Small Cap
📈Revenue Growth (YoY)
-57.7%
Declining
📊Gross Margin
99.6%
High
💵FCF Margin
-305.2%
Thin
⚖️P/S Ratio
1.3x
Cheap
Otter Score
96
Very Good
GOSSAMER BIO INC
GOSSAnalyst Ratings
Price
$11.58
Total
17
Raised
2
Lowered
5
Avg PT
$3.47
H / L
$9 / $0
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
HC Wainwright & Co. | Reiterated | Buy | 2026-09-21 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-08-14 | — | — |
Leerink Partners | Upgraded | Market Perform → Outperform | 2026-07-28 | $1.00 | −91.40% |
Barclays | Reiterated | Underweight | 2026-05-19 | $0.30 | −97.40% |
Cantor Fitzgerald | Downgraded | Overweight → Neutral | 2026-03-23 | — | — |
Oppenheimer | Reiterated | Outperform | 2026-03-05 | — | — |
Wedbush | Downgraded | Outperform → Neutral | 2026-02-24 | $1.00 | −91.40% |
UBS | Upgraded | Neutral → Buy | 2025-09-10 | $9.00 | −22.30% |
Goldman Sachs | Reiterated | Buy | 2025-05-16 | — | — |
Raymond James | Downgraded | Outperform → Market Perform | 2023-03-07 | $5.00 | −56.80% |
Guggenheim | Reiterated | Neutral | 2023-03-01 | — | — |
SMBC Nikko | Downgraded | Outperform → Neutral | 2022-12-07 | $3.00 | −74.10% |
SVB Leerink | Reiterated | Outperform | 2022-12-07 | — | — |
JP Morgan | Downgraded | Neutral → Underweight | 2022-12-07 | — | — |
Berenberg | Reiterated | Buy | 2019-10-30 | — | — |
Evercore ISI Group | Reiterated | Outperform | 2019-03-05 | — | — |
Bank of America | Reiterated | Buy | 2019-03-05 | — | — |
Institution
HC Wainwright & Co.
Reiterated · Buy · 2026-09-21
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-14
—
—
Leerink Partners
Upgraded · Market Perform → Outperform · 2026-07-28
$1.00
−91.40%
Barclays
Reiterated · Underweight · 2026-05-19
$0.30
−97.40%
Cantor Fitzgerald
Downgraded · Overweight → Neutral · 2026-03-23
—
—
Oppenheimer
Reiterated · Outperform · 2026-03-05
—
—
Wedbush
Downgraded · Outperform → Neutral · 2026-02-24
$1.00
−91.40%
UBS
Upgraded · Neutral → Buy · 2025-09-10
$9.00
−22.30%
Goldman Sachs
Reiterated · Buy · 2025-05-16
—
—
Raymond James
Downgraded · Outperform → Market Perform · 2023-03-07
$5.00
−56.80%
Guggenheim
Reiterated · Neutral · 2023-03-01
—
—
SMBC Nikko
Downgraded · Outperform → Neutral · 2022-12-07
$3.00
−74.10%
SVB Leerink
Reiterated · Outperform · 2022-12-07
—
—
JP Morgan
Downgraded · Neutral → Underweight · 2022-12-07
—
—
Berenberg
Reiterated · Buy · 2019-10-30
—
—
Evercore ISI Group
Reiterated · Outperform · 2019-03-05
—
—
Bank of America
Reiterated · Buy · 2019-03-05
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space